Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Elects Partnership Class of 29 and Counsel Class of 15 Across Europe and U.S.December 11, 2025EU Digital Omnibus: Implications for MedTech CompaniesDecember 10, 2025EU Digital Omnibus: The European Commission Proposes Important Changes to the EU’s Digital RulebookDecember 9, 2025Sidley Advises Bessemer Investors on Strategic Investment in XanitosDecember 9, 2025EU Digital Omnibus: The European Commission Proposes Important Changes to the EU's Digital RulebookDecember 9, 2025Sidley Advises Ancala on Acquisition of U.S. Chemical Infrastructure PortfolioDecember 4, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory